Evidence map›Paper›PMID 24978194›Full record

ArticlePloS one2014

Local transformations of androgens into estradiol by aromatase P450 is involved in the regulation of prolactin and the proliferation of pituitary prolactin-positive cells.

María José García Barrado, Enrique J Blanco, Marta Carretero Hernández, María Carmen Iglesias Osma, Manuel Carretero, Julio J Herrero, Deborah Jane Burks, José Carretero

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Relation among Aromatase P450 and Tumoral Growth in Human Prolactinomas.International journal of molecular sciences · 2017
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

María José García BarradoLaboratory of Neuroendocrinology, Institute of Neurosciences of Castilla y León, and Laboratory of Endocrine-Metabolic Diseases of IBSAL, University of Salamanca, Spain; Department of Physiology and Pharmacology, Faculty of Medicine, University of Salamanca, Spain.
Enrique J BlancoDepartment of Human Anatomy and Histology, Faculty of Medicine, University of Salamanca, Spain; Laboratory of Neuroendocrinology, Institute of Neurosciences of Castilla y León, and Laboratory of Endocrine-Metabolic Diseases of IBSAL, University of Salamanca, Spain.
Marta Carretero HernándezDepartment of Human Anatomy and Histology, Faculty of Medicine, University of Salamanca, Spain.
María Carmen Iglesias OsmaLaboratory of Neuroendocrinology, Institute of Neurosciences of Castilla y León, and Laboratory of Endocrine-Metabolic Diseases of IBSAL, University of Salamanca, Spain; Department of Physiology and Pharmacology, Faculty of Medicine, University of Salamanca, Spain.
Manuel CarreteroFaculty of Human and Social Sciences, University Pontificia of Salamanca, Spain.
Julio J HerreroDepartment of Surgery, Faculty of Medicine, University of Salamanca, Spain.
Deborah Jane BurksLaboratory of Neuroendocrinology, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
José CarreteroDepartment of Human Anatomy and Histology, Faculty of Medicine, University of Salamanca, Spain; Laboratory of Neuroendocrinology, Institute of Neurosciences of Castilla y León, and Laboratory of Endocrine-Metabolic Diseases of IBSAL, University of Salamanca, Spain.
Universidad de Salamanca · ESCentro de Investigacion Principe Felipe · ESInstituto de Estudios de Ciencias de la Salud de Castilla y León · ESInstituto de Investigación Biomédica de Salamanca · ESPontifical University of Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In previous studies we demonstrated the immunohistochemical expression of aromatase in pituitary cells. In order to determine whether pituitary aromatase is involved in the paracrine regulation of prolactin-producing pituitary cells and the physiological relevance of pituitary aromatase in the control of these cells, an in vivo and in vitro immunocytochemical and morphometric study of prolactin-positive pituitary cells was carried out on the pituitary glands of adult male rats treated with the aromatase antagonist fadrozole. Moreover, we analyzed the expression of mRNA for the enzyme in pituitary cells of male adult rats by in situ hybridization. The aromatase-mRNA was seen to be located in the cytoplasm of 41% of pituitary cells and was well correlated with the immunocytochemical staining. After in vivo treatment with fadrozole, the size (cellular and nuclear areas) of prolactin cells, as well as the percentage of prolactin-positive cells and the percentage of proliferating-prolactin cells, was significantly decreased. Moreover, fadrozole decreased serum prolactin levels. In vitro, treatment with fadrozole plus testosterone induced similar effects on prolactin-positive cells, inhibiting their cellular proliferation. Our results suggest that under physiological conditions aromatase P450 exerts a relevant control over male pituitary prolactin-cells, probably transforming testosterone to estradiol in the pituitary gland.

Indexed as

Cell ProliferationAnimalsAromataseAromatase InhibitorsCells, CulturedEstradiolFadrozoleLactotrophsMaleProlactinRatsRats, WistarRNA, MessengerTestosteroneAromataseAromatase InhibitorsEstradiolFadrozoleProlactinRNA, MessengerTestosterone

Identifiers

PMID24978194
PMCPMC4076335
OpenAlexW2065102240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.